Effect of Virechana Karma and Durvadi lepa in Ring worm

A comparative clinical study of Virechana Karma and Durvadi Lepa in the management of Dadru - Dadru

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025477

Enrollment

Registered

2020-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Virechana Karma and Durvadi Lepa: Durvadi Lepa for L/A once daly for 4weeks Virechana Karma once with Durvadi Lepa twice daily for 4 weeks Control Intervention1: Terbinafin ointment: Te

Eligibility

Inclusion criteria

Inclusion criteria: Patient between age group 20-40 years, only diagnosed cases of tinea infection

Exclusion criteria

Exclusion criteria: Age group less than 20 years and more than 40 years, any sensitivity to the preparation, skin cancer, psoriasis, eczema etc associated fungal infections, diabetic and cardiac patient, pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
assessment will be done on the basis of prepared pro forma and improvement in sign and symptoms of DadruTimepoint: total duration of treatment is 1 month. 4 follow-ups at the interval of 7 days	—

Secondary

Measure	Time frame
Improvement in criteria listed in scales.Timepoint: total duration of treatment is 1 month. 4 follow-ups at the interval of 7 days	—

Countries

India

Contacts

Public ContactDr Sudama Singh Yadav

Banaras Hindu University

drssyadav11@gmail.com9838164114

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026